000 02397 a2200637 4500
005 20250516133355.0
264 0 _c20130618
008 201306s 0 0 eng d
022 _a1476-4598
024 7 _a10.1186/1476-4598-12-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, Yuanyuan
245 0 0 _aEpigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
_h[electronic resource]
260 _bMolecular cancer
_cFeb 2013
300 _a9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnticarcinogenic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Agents, Hormonal
_xadministration & dosage
650 0 4 _aAzacitidine
_xanalogs & derivatives
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDNA (Cytosine-5-)-Methyltransferase 1
650 0 4 _aDNA (Cytosine-5-)-Methyltransferases
_xmetabolism
650 0 4 _aDecitabine
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aDrug Synergism
650 0 4 _aEpigenesis, Genetic
_xdrug effects
650 0 4 _aEstradiol
_xpharmacology
650 0 4 _aEstrogen Receptor alpha
_xgenetics
650 0 4 _aFemale
650 0 4 _aGene Expression
_xdrug effects
650 0 4 _aGenistein
_xadministration & dosage
650 0 4 _aHistone Deacetylase 1
_xmetabolism
650 0 4 _aHistone Deacetylase Inhibitors
_xpharmacology
650 0 4 _aHistones
_xmetabolism
650 0 4 _aHumans
650 0 4 _aHydroxamic Acids
_xpharmacology
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aMice, Transgenic
650 0 4 _aProliferating Cell Nuclear Antigen
_xmetabolism
650 0 4 _aPromoter Regions, Genetic
650 0 4 _aTamoxifen
_xadministration & dosage
650 0 4 _aTumor Burden
_xdrug effects
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aMeeran, Syed M
700 1 _aPatel, Shweta N
700 1 _aChen, Huaping
700 1 _aHardy, Tabitha M
700 1 _aTollefsbol, Trygve O
773 0 _tMolecular cancer
_gvol. 12
_gp. 9
856 4 0 _uhttps://doi.org/10.1186/1476-4598-12-9
_zAvailable from publisher's website
999 _c22475495
_d22475495